Tempus AI (TEM) stock surged 13.4% on Thursday, hitting a new 52-week high of $86. The upside came after the health ...

Tempus AI (NASDAQ:TEM) wasn’t that remarkable compared to most other AI high-fliers in the past year. The stock was very volatile in the past year and declined significantly in December 2024 ...

While it is currently predicted that less than 1% of bacterial organisms can be cultured in the lab, meta-omics (particularly metagenomics) has been the most popular microbiology methodology for ...

In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. Optimistic sentiment continued to drive Wall Street on Thursday, with all major ...

This feature was written using content from our recent Multi-Omics Playbook, which you can download for free here. Last week, we took a look at the power of each of the commonly used omics in the life ...

Shares of Tempus AI (TEM) are down 92c, or 2%, to $49.53 in Thursday morning trading after it was disclosed in a regulatory filing last night that founder and CEO Eric Lefkofsky disposed of ...

In addition, the multi-omics data provided a good opportunity to investigate the underlying molecular characteristics of Acalisib (PI3K inhibitor) resistance. In the Spearman correlation analysis ...

Tempus AI shares surged more than 35% on Tuesday after former House Speaker Nancy Pelosi disclosed call options expiring in 2026. Several AI-related stocks are rising Wednesday after U.S ...

Toru Hanai / Bloomberg via Getty Images Shares of Tempus AI had their best day on record on Tuesday after the company launched an AI-powered health concierge. The stock also got a boost from ...